Paul founded Intercytex in 1999 and is its Chief Scientific Officer. He has over 17 years of experience in the commercial development of cell therapy. Prior to founding Intercytex, he was VP Research at Organogenesis Inc. He is a principal inventor on several patents related to regenerative medicines including the wound repair stimulant, Apligraf®.